Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:2265-2272

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiao, J.-H.
Right arrow Articles by Lusis, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiao, J.-H.
Right arrow Articles by Lusis, A. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:2265-2272.)
© 1995 American Heart Association, Inc.


Articles

Genetic Determination of Cartilaginous Metaplasia in Mouse Aorta

Jian-Hua Qiao; Michael C. Fishbein; Linda L. Demer; Aldons J. Lusis

From the Department of Medicine (J.-H.Q., L.L.D., A.J.L.) and the Department of Microbiology and Molecular Genetics and Molecular Biology Institute (J.-H.Q., A.J.L.), University of California, Los Angeles, the Department of Pathology, Cedars-Sinai Medical Center (M.C.F.), and the Department of Physiology (L.L.D.), University of California, Los Angeles.

Correspondence to Jian-Hua Qiao, MD, Division of Cardiology, Department of Medicine, 47-123 CHS, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90024-1679.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract Calcification frequently occurs in atherosclerotic plaques in humans, but the cellular and genetic factors contributing to this pathological trait are unknown. We previously reported that the arterial calcification among inbred strains is genetically determined, and we now report that cartilaginous metaplasia, associated with the presence of arterial chondrocytes that express type II collagen, may underlie this calcification. Both uncalcified and calcified cartilaginous metaplasia were often colocalized with aortic atheromatous lesions and calcification, and clear genetic differences were observed in the occurrence of aortic cartilaginous metaplasia among inbred strains. Analysis of a genetic cross between strains C57BL/6J (exhibiting aortic cartilaginous metaplasia) and C3H/HeJ (no aortic cartilaginous metaplasia) revealed a recessive inheritance pattern; thus, F1 mice were entirely devoid of cartilaginous metaplasia, in common with the C3H/HeJ parental strain. Analyses of an F2 cross and a set of recombinant inbred strains derived from parental strains C57BL/6J and C3H/HeJ were consistent with a major gene effect exhibiting incomplete penetrance. The occurrence of aortic calcification was correlated with the occurrence of cartilaginous metaplasia in these genetic crosses, suggesting a link between the traits. Finally, we observed widespread calcified cartilaginous metaplasia within spontaneous atherosclerotic lesions in mice targeted for a null mutation in the apoE gene, suggesting that cartilaginous metaplasia is a potential pathway for artery wall calcification associated with the atherosclerotic plaque.


Key Words: atherosclerosis • calcification • genetics • mouse strains, inbred • artery wall


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Arterial calcification has been associated with occlusive coronary artery disease in human populations1 2 3 4 5 6 7 8 9 10 and may contribute to plaque rupture and myocardial infarction.1 5 The presence of coronary artery calcification as detected by fluoroscopy has been shown to have prognostic value in selected populations.6 Calcification is also a major complication limiting the longevity of bioprosthetic valves.11 12 13 Calcification is a complex process that occurs in normal biological processes (eg, the calcium mineral deposition of bone and dentin) and numerous pathological conditions involving irreversible degeneration or cell death (eg, advanced atherosclerotic plaque, tuberculosis, and neoplasms). The factors contributing to arterial calcification are unknown, but the fact that some plaques exhibit considerable calcification whereas others are free of calcification suggests that either genetic or environmental factors are likely to be of importance.

We have reported that arterial calcification is influenced by both genetic and dietary factors in a mouse model.14 Aortic calcification is often accompanied by the presence of cartilaginous metaplasia. In the present study, we observed a clear genetic difference in the occurrence of aortic cartilaginous metaplasia among inbred strains. The cartilaginous metaplasia was frequently associated with arterial calcification, and in one set of RI strains the two traits tended to cosegregate. The calcified cartilaginous metaplasia was also present in the atherosclerotic plaques in apoE gene–targeted (knockout) mice, which exhibit severe spontaneous arterial atherosclerosis and calcification when fed a regular chow diet.14 15 16 17 18 These findings suggest a potential relation among atherosclerosis, cartilaginous metaplasia, and calcification.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Mice and Diets
Inbred strains of mice were obtained from the Jackson Laboratory (Bar Harbor, Me), except the C57BL/10ScSnA and C3H/DiSnA strains (from Dr Peter Demant, Netherlands Cancer Institute, Amsterdam, Netherlands), apoE knockout mice (a gift from Dr N. Maeda, University of North Carolina, Chapel Hill),15 and MHC class II–deficient mice (purchased from GenPharm International, Mountain View, Ca). BxH F2 mice were bred in our laboratory. The mice were fed either standard rodent chow containing 4% fat (Purina 5001) or a high-fat, high-cholesterol (atherogenic) diet (TD 90221, Food-Tek, Inc) containing 15% (wt/wt) fat, 1.25% cholesterol, and 0.5% cholic acid.14 Animals were housed 3 to 5 per cage and maintained in a temperature-controlled room with a 12-hour light/dark cycle. All mice were females between 4 and 6 months of age at the time of euthanasia, except for the atherogenic diet–fed group of DBA/2J mice, which were older than 10 months of age, and chow-fed groups of BxH F1 and apoE knockout mice, which comprised both males and females.

Histopathologic and Immunohistochemical Studies
Animals were killed by cervical dislocation after isofluorane (Forane, Anaquest) anesthesia. The heart and proximal aorta (including the aortic arch) were excised and washed in phosphate-buffered saline. The basal portion of the heart and the root of the aorta were embedded in OCT compound (Tissue-Tek) and frozen on dry ice. Serial 10-µm-thick cryosections (every fifth section from the lower portion of the ventricles to the appearance of aortic valves, every other section in the region of the aortic sinus, and every fifth section from the disappearance of the aortic valves to the aortic arch) were collected on poly-D-lysine coated slides and stored at -70°C until histological staining was done.14

Sections were stained with oil red O and hematoxylin and counterstained with fast green for the identification of atheromatous lesions (fatty streaks), arterial calcification, and aortic cartilaginous metaplasia.14 19 20 21 For confirmation of calcium mineral deposits, representative sections were also stained by the alizarin red S and von Kossa techniques.14 Sections of mouse trachea and femoral bone served as positive controls for cartilage (chondrocytes) and calcification. Every stained section was examined by light microscopy for the presence of cartilage and calcium deposits in the arterial wall. Cartilaginous metaplasia was defined as the presence of chondrocytes in lacunae within a collagenous mucopolysaccharide–rich matrix in aortic wall or valve attachments. Mice were considered positive if cartilage and/or calcium deposits were observed in the aortic wall in one or more sections.

For immunochemical identification of the chondrocytes present in the aorta, we applied rabbit anti-human collagen type II polyclonal antiserum (Chemicon International Inc), which cross-reacted with chondrocytes of mouse tracheal wall, and the avidin–biotinylated peroxidase system to stain frozen mouse aortic sections that contained loci of cartilaginous metaplasia. The final working dilution of this antibody was 1:200, and omission of primary antibody or the use of other nonrelevant rabbit antiserum was performed as a negative control. The immunohistochemical staining procedures were previously described in detail.14 20

Statistical Analysis
Data analysis was performed using STATVIEW (Student's t test, {chi}2 analysis, and ANOVA) software for the Macintosh personal computer.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Aortic Cartilaginous Metaplasia
During the course of studies of fatty streak formation in mouse aorta, we observed areas of cartilage-like tissue in the proximal aorta of certain inbred strains that closely resembled cartilage in the tracheal wall (see inset, Fig 1ADown). Immunohistochemical staining confirmed that the tissue had undergone cartilaginous metaplasia. Type II collagen, the major matrix protein of cartilage cells, is a marker for cartilage. A polyclonal antibody, prepared in rabbit anti-human type II collagen, was found to cross-react well with mouse type II collagen as judged by strong positive reaction with mouse tracheal wall chondrocytes (Fig 2BDown). Very similar immunoreactivity of this antibody was observed in areas of the aorta containing the cartilage-like tissue (Fig 2ADown). Calcium-mineral deposition was confirmed by histochemical staining using the alizarin red S and von Kossa staining techniques (see inset, Figs 2A as well as Fig 3BDown and 3CDown), with mouse femoral bone tissue serving as a positive control.



View larger version (2K):
[in this window]
[in a new window]
 
Figure 1. Facing page. Photomicrograph showing aortic cartilaginous metaplasia in inbred mice. A, Area of cartilaginous metaplasia in a normal aortic valve commissure of strain MRL/MPJ-lpr/lpr mice maintained on chow. Some cells contained lipophilic staining with oil red O. Magnification x50. Inset, chondrocytes in mouse tracheal wall. Magnification x40. B, Area of cartilaginous metaplasia (arrow) colocalized with fatty streaks (*) in a valve attachment from a strain C57BL/6J mouse maintained for 15 weeks on an atherogenic diet. Magnification x40. C, Area of cartilaginous metaplasia in the aortic ring with fatty lesions (arrowhead) from a strain C57BL/6J mouse maintained for 15 weeks on an atherogenic diet. Magnification x33. D, Area of calcified cartilaginous metaplasia (arrow) in aortic wall within fatty lesions (*) from a strain C57BL/6J mouse maintained for 15 weeks on the atherogenic diet. Magnification x50. E, A large, calcified area of cartilaginous metaplasia in aortic wall from a BxHRI-14 strain mouse maintained for 15 weeks on an atherogenic diet. Magnification x33. F, An adjacent section of E shows cartilaginous metaplasia (arrow) copresent with calcification. Magnification x50. All sections were stained with oil red O, hematoxylin, and fast green.



View larger version (2K):
[in this window]
[in a new window]
 
Figure 2. Photomicrographs showing immunohistochemical studies for type II collagen. A, Positive immunoreactivity for type II collagen is shown in a locus of cartilaginous metaplasia (*) in the aortic wall from a strain C57BL/6J mouse maintained on a chow diet. There was immunoreactivity for this antibody in areas of the aortic valve and valve attachment. The explanation for this is unknown, although it could be due to the presence of type II collagen in these regions or cross-reactivity of the antibody with other collagen species. Magnification x50. Inset, von Kossa staining of the same type of cartilaginous metaplasia (uncalcified) in the aortic wall. Magnification x25. B, Positive control for type II collagen is shown in the region of the tracheal wall containing cartilage. Magnification x50. C, Negative control (omission of primary antibody) is shown in a sequential section of B. Magnification x50. Sections were counterstained with hematoxylin.



View larger version (2K):
[in this window]
[in a new window]
 
Figure 3. Photomicrographs showing cartilaginous metaplasia in nude, strain C57BL/6J (A through C) and apoE-deficient mice (D through F). A, Calcified and uncalcified cartilaginous metaplasia (arrow) in aortic wall with fatty streak lesions (*). Magnification x100. B, The presence of calcium mineral deposits was confirmed in a sequential section by alizarin red S staining. Magnification x50. C, Another sequential section stains positive for von Kossa stain. Magnification x50. D, Cartilaginous metaplasia (arrow) is shown within an atheromatous lesion in the aortic arch. Asterisk shows another large atherosclerotic plaque. Magnification x10. E, High power view of cartilaginous metaplasia in D. Magnification x25. F, Cartilaginous metaplasia is shown in an atherosclerotic plaque of pulmonary artery. Magnification x66. The nude, strain C57BL/6J mice were maintained for 15 weeks on an atherogenic diet, whereas apoE knockout mice were maintained on chow. With the exception of sections shown in B and C, all sections were stained with oil red O, hematoxylin, and fast green.

Cartilaginous metaplasia occurred most often within the aortic ring and valve commissure attachment areas (proximal aorta) (Fig 1AUp through 1C). Both uncalcified and calcified forms of cartilaginous metaplasia were observed in the normal aorta (mice fed chow) and the aorta with atheromatous lesions (mice fed the high-fat diet) (Fig 1Up). No definite cartilaginous metaplasia was observed in the coronary arteries and cardiac valves. The distal thoracic and abdominal aorta were not examined in this study. Loci of uncalcified cartilaginous metaplasia frequently exhibited positive staining with the lipophilic dye oil red O (Fig 1AUp through 1C and 1F), which is a typical histological feature of hyaline cartilage. We frequently observed typical arterial calcification in sections adjacent to those containing calcified cartilaginous metaplasia (Fig 1EUp and 1FUp). For example, among C57BL/6J mice fed the atherogenic diet that stained positively (and that exhibited calcified cartilaginous metaplasia), 94% (15 of 16) also had typical aortic calcification in the adjacent sections. The characteristics of histological staining for uncalcified cartilaginous metaplasia, calcified cartilaginous metaplasia, and typical calcification are shown in Table 1Down.


View this table:
[in this window]
[in a new window]
 
Table 1. Histological Staining

Genetic Control of Cartilaginous Metaplasia
Inbred strains of mice differed in the occurrence of aortic cartilaginous metaplasia. For example, on a low-fat–chow diet, aortic cartilaginous metaplasia was observed in about 23% of strain C57BL/6J mice, whereas no aortic cartilage was observed in several other common inbred mouse strains, such as BALB/cJ, A/J, and C3H/HeJ (Table 2Down). Two MRL/MPJ substrains exhibited a very high frequency of aortic cartilaginous metaplasia (57% and 89%). Feeding the mice an atherogenic diet for 15 weeks did not significantly influence the occurrence of aortic cartilaginous metaplasia in most of the inbred strains (Table 2Down).


View this table:
[in this window]
[in a new window]
 
Table 2. Distribution of Aortic Cartilaginous Metaplasia Among Inbred Strains of Mice Fed Either Chow or an Atherogenic Diet for 15 Weeks

Differences were present between C57BL/6J and MRL/MPJ substrains in terms of the ratio of subtypes of aortic cartilaginous metaplasia (calcified versus uncalcified). For example, none of the aortic cartilage (0 of 25, 0%) in MRL/MPJ substrains fed either chow or an atherogenic diet was calcified. However, nearly one half of the aortic cartilage (4 of 9, 44%) in strain C57BL/6J mice fed chow was calcified. Interestingly, the atherogenic diet appeared to increase the occurrence of calcified aortic cartilage in this strain. Thus, 4 of 39 (10%) of mice in the chow-fed group and 16 of 60 (27%) in the atherogenic diet–fed group of C57BL/6J mice exhibited calcified cartilaginous metaplasia ({chi}2=3.95, P<.05).

To evaluate whether immunological factors contribute to the process of aortic cartilaginous metaplasia, we examined two strains of mice that lack an intact immune system. The occurrence of aortic cartilaginous metaplasia in these mice is shown in Table 2Up and Fig 3AUp through 3C. Nude mice22 ; class II MHC antigen–deficient mice,23 which lack CD4+ T helper lymphocytes; and op/op mice24 all had the ability to produce the aortic cartilaginous metaplasia.

Inheritance of Aortic Cartilaginous Metaplasia
Strain C57BL/6J mice exhibited a relatively high occurrence of aortic cartilaginous metaplasia on both chow and atherogenic diets, whereas strain C3H/HeJ mice exhibited no evidence of this trait. The differences between the two strains were significant for both mice fed chow and those fed a high-fat diet. To further examine the role of genetics in development of aortic cartilaginous metaplasia, we characterized F1 and F2 progeny as well as a set of BxH RI strains for the occurrence of aortic cartilaginous metaplasia (Tables 3Down and 4Down).


View this table:
[in this window]
[in a new window]
 
Table 3. Frequency of Aortic Cartilaginous Metaplasia in BxH Progeny


View this table:
[in this window]
[in a new window]
 
Table 4. Aortic Cartilaginous Metaplasia in C57BL/6J, C3H/HeJ, and BxH RI Mouse Strains Fed an Atherogenic Diet for 15 Weeks

Aortic cartilaginous metaplasia was absent in all BxH F1 progeny in common with the C3H/HeJ parent, indicating that this trait exhibits recessive inheritance. Seven percent of the BxH F2 progeny exhibited aortic cartilaginous metaplasia. This is not significantly different from the 8% predicted for a single, recessive mendelian gene with 33% penetrance (33% is the average occurrence in strain C57BL/6J mice fed either chow or a high-fat diet, Table 3Up). Among positive F2 progeny that exhibited aortic cartilaginous metaplasia, four (4 of 13, 31%) were calcified.

We further examined the inheritance of aortic cartilaginous metaplasia in a set of BxH RI strains. Each member of the BxH RI strains contains a unique mixture of genes derived from the parental strains. These recombinant genotypes have been fixed by many generations of inbreeding.25 26 These strains have been previously typed for aortic calcification and aortic atherogenesis.14 21 The distribution of aortic cartilaginous metaplasia among the RI strains is presented in Table 4Up. The majority of the BxH RI strains (7 of 10) exhibited no aortic cartilaginous metaplasia, resembling the phenotype of the C3H/HeJ parent (0%), whereas 3 of 10 strains developed this trait (Table 4Up). If cartilaginous metaplasia was determined by a single major gene, it would be expected to occur in {approx}50% of the RI strains; this is not significantly different from the observed value. These patterns of inheritance are consistent with (but do not prove) the hypothesis that the aortic cartilaginous metaplasia is determined by a single major gene exhibiting incomplete penetrance.

The occurrence of aortic cartilaginous metaplasia was significantly correlated with calcification in the aortic root among the BxH RI strains (r=.76, P=.01) (Table 4Up). Clearly, however, there are additional factors contributing to calcification. For example, C3H/HeJ and several other common laboratory inbred strains exhibited no evidence of arterial cartilaginous metaplasia, yet they developed arterial calcification in aorta and coronary arteries.14 Given the likely complexity of calcification, multiple mechanisms may be involved.

Cartilaginous Metaplasia in ApoE Knockout Mice
Using gene targeting techniques, apoE knockout mice recently were created.15 16 These genetically manipulated mice develop severe hypercholesterolemia due to delayed clearance of large atherogenic particles from the circulation and exhibit the entire spectrum of lesions observed during human atherogenesis, from fatty streaks to complex lesions.14 15 16 17 18 One feature of the apoE knockout mice is enhanced artery wall calcification compared with most laboratory-inbred strains.14 We examined 6 apoE knockout homozygotes of a mixed genetic background derived from mouse strains 129/J and C57BL/6J. All these mice (6 of 6, 100%) developed extensive spontaneous atherosclerosis at 4 to 6 months old, and 4 (4 of 6, 67%) exhibited typical calcification in aortic atheromatous lesions. Calcified cartilaginous metaplasia was found in 3 of 6 apoE knockout mice (50%). Unlike strain C57BL/6J mice, in which most of the cartilaginous metaplasia was located in aortic ring or aortic valve attachments (32 of 33, 97%), apoE knockout mice exhibited cartilaginous metaplasia within the atherosclerotic plaques in the aortic arch (3 of 3, 100%) (Fig 3DUp and 3EUp) and pulmonary artery (1 of 3, 33%) (Fig 3FUp). Thus, either hypercholesterolemia or the consequent atherosclerosis appears to promote cartilaginous metaplasia. It is noteworthy that in strain C57BL/6J mice, both atherosclerosis and cartilaginous metaplasia are largely restricted to the proximal aorta, whereas in apoE knockout mice, both traits are more widely dispersed.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Our results indicate a genetic component contributing to aortic cartilaginous metaplasia and provide presumptive evidence that cartilaginous metaplasia is one of the pathways contributing to arterial calcification. The finding that different inbred strains of mice show striking differences in cartilaginous metaplasia despite being maintained under very similar environmental conditions indicates the existence of hereditary factors contributing to the trait. This possibility is supported by the inheritance patterns observed in crosses between strain C57BL/6J (susceptible) and strain C3H/HeJ (resistant) mice. The explanation for the incomplete penetrance of the trait is unclear. It may be related to subtle environmental or developmental influences or it could be due to stochastic or sampling factors. Results of both the F2 cross and the RI strain studies are consistent with the possibility that a major gene underlies the development of cartilaginous metaplasia, but additional studies are required to demonstrate this.

A significant correlation between the occurrence of cartilaginous metaplasia and aortic calcification was observed among the BxH RI strains (r=.76, P=.01). Moreover, calcification was frequently observed adjacent the sites of cartilaginous metaplasia in histological studies. These findings support the possibility that cartilaginous metaplasia may be one mechanism contributing to arterial calcification. In addition, studies of genetically engineered mice that exhibit extreme hypercholesterolemia because of a null mutation of the apoE gene (apoE knockout mice) suggest a link among cartilaginous metaplasia, calcification, and atherogenesis. Thus, in contrast to normal inbred strains of mice, apoE knockout mice exhibit large and widely dispersed atherosclerotic lesions throughout the aorta.14 15 16 17 18 Whereas cartilaginous metaplasia and arterial calcification in normal mice were restricted to the proximal aorta, apoE knockout mice exhibited both in the aortic arch.

The fact that arterial calcification occurs in some strains in the absence of detectable cartilaginous metaplasia suggests that there may be different pathways leading to calcification or that the rate of progression to calcification differs between strains. Indeed, the fact that calcified cartilaginous metaplasia was present in strain C57BL/6J but not in MRL/MPJ substrains suggests that genetic factors also affect the calcification of cartilagenous metaplasia. There are a number of bone-associated proteins and regulatory factors that may contribute to the observed genetic differences in cartilaginous metaplasia and calcification. Our strategy is first to map the genes responsible and then to focus on any genes that reside in the chromosomal region identified.

Cartilaginous metaplasia in cardiovascular tissues has been reported in mice, rats, rabbits, and other animals, as well as humans.27 28 29 30 31 In most instances the cartilage is hyaline, but in sheep the cartilage may change to bone through enchondrial ossification.28 The mechanisms responsible for arterial wall cartilaginous metaplasia are unknown. Aortic wall hyaline cartilage was induced in chickens by intramural injection with carrageenan.32 It has been reported that mechanical stress (combined compression and rotation) induced metaplastic changes from typical elongated fibrous tissue cells to typical rounded cartilage cells.33 Our observation that cartilaginous metaplasia is localized mainly in the aortic valve attachments, the region that faces strong mechanical stress during the cardiac cycle, is consistent with the hypothesis that mechanical stress is one factor promoting cartilaginous metaplasia in the mouse aortic wall. However, the significant differences in the occurrence of cartilaginous metaplasia among several common inbred strains of mice suggest that genetic factors also play an important role. Although the mechanism of conversion of hyaline (uncalcified) cartilage to calcified cartilage is unclear, experiments in avian embryos demonstrate that the constitutive expression of the v-myc oncogene maintains chondrocytes in stage I (active proliferation and synthesis of type II collagen) and prevents these cells from reconstituting hypertrophic calcifying cartilage.34 In vitro data also suggest that c-fos oncogene may play a crucial role in the osteogenic differentiation of cartilage.35

It is unknown whether the immune system and inflammatory mechanisms are involved in physiological and pathological calcification. It has been reported that experimental calcification of porcine bioprosthetic xenograft tissue does not require normal T-lymphocyte activity in nude mice.36 The finding of calcification of rat aorta in a grafted intraperitoneal (0.22-µm) millipore chamber suggests that calcification can occur in the absence of scavenging by inflammatory cells such as macrophages.37 Our results in nude and op/op mice also support the notion that normal T lymphocytes and macrophages are not essential for hyaline or calcified arterial wall cartilaginous metaplasia.

Although calcification is a prominent feature of atherosclerotic lesions, little is known about the biology of arterial wall calcification. Traditionally, calcification has been considered to be an end-stage degenerative process associated with complex atherosclerosis. However, recent observations of expression of bone-associated proteins in atherosclerotic lesions suggest that human arterial calcification is an active, regulated process.38 39 40 41 42 43 44 45 A combination of in situ hybridization and immunohistochemical techniques has revealed that smooth muscle cells as well as macrophages in human atheromatous plaques can express osteopontin mRNA and protein.40 41 42 43 Extracellular osteopontin protein is often found in areas of dense connective tissue that is colocalized with calcification in the plaque.43 44 Results of other experiments have suggested the presence of a unique subpopulation of artery wall cells, called calcifying vascular cells, in the wall of human and bovine arteries.39 45 Although cartilaginous metaplasia has not been identified in human atherosclerotic lesions, our studies of aortic cartilaginous metaplasia and calcification in mice suggest that some vessel wall cell populations can differentiate to chondrocytes, form cartilage, and contribute to calcification. This hypothesis was supported by our finding that the relatively advanced atherosclerotic lesions present in apoE knockout mice were associated with both cartilaginous metaplasia and calcification. Thus, cartilaginous metaplasia is a potential pathway of artery wall calcification in the atherosclerotic plaque. The study of genetic factors contributing to arterial cartilaginous metaplasia and calcification may provide an understanding of the molecular and cellular mechanisms involved in these processes.


*    Selected Abbreviations and Acronyms
 
BxH = mouse strain derived from parental strains C57BL/6J and C3H/HeJ
MHC = major histocompatibility complex
nude = (mice that are) athymic and lacking in cellular immunity
op/op = homozygotes of osteopetrotic mice, which lack functionally active macrophage colony–stimulating factor
RI = recombinant inbred


*    Acknowledgments
 
This work was supported in part by National Institutes of Health award HL-30568 and the Laubisch Fund, University of California, Los Angeles. We wish to thank X.-P. Wang and P.-Z. Xie for their excellent histological technical assistance, F. Liao for the maintenance of strain BxH genetically crossed mice, A. Fyfe for the maintenance of immune-deficient mice, S. Shoemaker for the maintenance of op/op mice, and S. Zhang and N. Maeda (University of North Carolina) for providing us with mice lacking apoE.

Received November 3, 1994; accepted May 24, 1995.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am J Roentgenol. 1964;92:865-871.
  2. Blankenhorn DH, Stern D. Calcification of the coronary arteries. Am J Roentgenol. 1959;81:772-777.
  3. Eggen DA, Strong JP, McGill HC Jr. Coronary calcification: relationship to clinically significant coronary lesions and race, sex, and topographic distribution. Circulation. 1965;32:948-955. [Abstract/Free Full Text]
  4. McCarthy JH, Palmer FJ. Incidence and significance of coronary artery calcification. Br Heart J. 1974;36:499-506. [Free Full Text]
  5. Warburton RK, Tampas JP, Soule AB, Taylor HC III. Coronary artery calcification: its relationship to coronary artery stenosis and myocardial infarction. Radiology. 1968;91:109-115. [Medline] [Order article via Infotrieve]
  6. Margolis JR, Chen JTT, Kong Y, Peter RH, Behar VS, Kisslo JA. The diagnostic and prognostic significance of coronary artery calcification: a report of 800 cases. Radiology. 1980;137:609-616. [Abstract/Free Full Text]
  7. Breen JF, Sheedy PF II, Schwartz RS, Stanson AW, Kaufmann RB, Moll PP, Rumberger JA. Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease. Radiology. 1992;185:435-439. [Abstract/Free Full Text]
  8. Witteman JCM, Kannel WB, Wolf PA, Grobbee DE, Hofman A, D'Agostino RB, Cobb JC. Aortic calcified plaques and cardiovascular disease (the Framingham study). Am J Cardiol. 1990;66:1060-1064. [Medline] [Order article via Infotrieve]
  9. Simons DB, Schwartz RS, Edwards WD, Sheedy PF, Breen JF, Rumberger JA. Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol. 1992;20:1118-1126. [Abstract]
  10. Bormann JL, Stanford W, Stenberg RG, Winniford MD, Berbaum KS, Talman CL, Galvin JR. Ultrafast computed tomographic detection of coronary artery calcification as an indicator of stenosis. Am J Card Imaging. 1992;6:191-196.
  11. Fishbein MC, Gissen SA, Collins SJJ Jr, Barsamian EM, Cohn LH. Pathologic findings after cardiac valve replacement with glutaraldehyde-fixed porcine valves. Am J Cardiol. 1977;40:331-337. [Medline] [Order article via Infotrieve]
  12. Silver MM, Pollock J, Silver MD, William WG, Trusler GA. Calcification in porcine xenograft valves in children. Am J Cardiol. 1980;45:685-696.[Medline] [Order article via Infotrieve]
  13. Ishihara T, Ferrans VJ, Jones M, Cabin HS, Roberts WC. Calcific deposits developing in a bovine pericardial bioprosthetic valve 3 days after implantation. Circulation. 1981;63:718-723. [Abstract/Free Full Text]
  14. Qiao J-H, Xie P-Z, Fishbein MC, Kreuzer J, Drake TA, Demer LL, Lusis AJ. Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb. 1994;14:1480-1497. [Abstract/Free Full Text]
  15. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471. [Abstract/Free Full Text]
  16. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353. [Medline] [Order article via Infotrieve]
  17. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140. [Abstract/Free Full Text]
  18. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apoE: evaluation of lesional development and progression. Arterioscler Thromb. 1994;14:141-147. [Abstract/Free Full Text]
  19. Mehrabian M, Qiao J-H, Hyman R, Ruddle D, Laughton C, Lusis AJ. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscler Thromb. 1993;11:947-957. [Abstract/Free Full Text]
  20. Qiao J-H, Castellani LW, Fishbein MC, Lusis AJ. Immune-complex-mediated vasculitis increases coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler Thromb. 1993;13:932-943. [Abstract/Free Full Text]
  21. Qiao J-H, Welch CL, Xie P-Z, Fishbein MC, Lusis AJ. Involvement of the tyrosinase gene in the deposition of cardiac lipofuscin in mice: association with aortic fatty streak development. J Clin Invest. 1993;92:2386-2393.
  22. Pantelouris EM. Absence of thymus in a mouse mutant. Nature. 1968;217:370-372. [Medline] [Order article via Infotrieve]
  23. Grusby MJ, Johnson RS, Papioannou VE, Glimcher LH. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science. 1991;253:1417-1420. [Abstract/Free Full Text]
  24. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, Ahmed-Ansari A, Sell KW, Pollaed JW, Stanley ER. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A. 1990;87:4828-4832. [Abstract/Free Full Text]
  25. Bailey DW. Recombinant-inbred strains: an aid to finding identity, linkage and function of histocompatibility and other genes. Transplantation. 1971;11:325-327. [Medline] [Order article via Infotrieve]
  26. Taylor BA. Recombinant inbred strains: use in gene mapping. In: HC Morse III, ed. Origins of Inbred Mice. New York, NY: Academic Press; 1978:423-438.
  27. Jokinen MP, Clarkson TB, Prichard RW. Recent advances in molecular pathology: animal models in atherosclerosis research. Exp Mol Pathol. 1985;42:1-28. [Medline] [Order article via Infotrieve]
  28. Hueper WC. Cartilaginous foci in the hearts of white rats and of mice. Arch Pathol. 1939;27:466-468.
  29. Hollander CF. Cartilaginous focus at the base of the non-coronary semilunar valve of the aorta in rats of different ages. Exp Gerontol. 1968;3:303-307. [Medline] [Order article via Infotrieve]
  30. Seemayer TA, Thelmo WL, Morin J. Cartilaginous transformation of the aortic valve. Am J Clin Pathol. 1973;60:616-620. [Medline] [Order article via Infotrieve]
  31. Groom DA, Starke WR. Cartilaginous metaplasia in calcific aortic valve disease. Am J Clin Pathol. 1990;93:809-812. [Medline] [Order article via Infotrieve]
  32. McCandless EL, Lehoczky JM, Rodbard S. Aortic cartilage produced by intramural carrageenan. Arch Pathol. 1963;75:507-516. [Medline] [Order article via Infotrieve]
  33. Scapinelli R, Little K. Observations on the mechanically induced differentiation of cartilage from fibrous connective tissue. J Pathol. 1970;101:85-91. [Medline] [Order article via Infotrieve]
  34. Quarto R, Dozin B, Tacchetti C, Robino G, Zenke M, Campanile G, Cancedda R. Constitutive myc expression impairs hypertrophy and calcification in cartilage. Dev Biol. 1992;149:168-176. [Medline] [Order article via Infotrieve]
  35. Closs EI, Beatrice Murray A, Schmidt J, Schon A, Erfle V, Gunter Strauss P. c-fos expression precedes osteogenic differentiation of cartilage cells in vitro. J Cell Biol. 1990;111:1313-1323. [Abstract/Free Full Text]
  36. Levy RJ, Schoen FJ, Howard SL. Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes. Am J Cardiol. 1983;52:629-631. [Medline] [Order article via Infotrieve]
  37. Kim KM. Matrix vesicle calcification of rat aorta in Millipore chambers. Metab Bone Dis Rel Res. 1978;1:213-217.
  38. Demer LL, Watson KE, Bostrom K. Mechanism of calcification in atherosclerosis. Trends Cardiovasc Med. 1994;4:45-49.
  39. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91:1800-1809.
  40. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin mRNA and protein are overexpressed in human coronary atherectomy specimens: clues to lesion calcification. Circulation. 1993;88:I-619. Abstract.
  41. Shanahan CM, Cary NRB, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994;93:2393-2402.
  42. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim H-M, Kitamura Y, Yutani C, Nomura S. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. Am J Pathol. 1993;143:1003-1008. [Abstract]
  43. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 1994;14:1648-1656. [Abstract/Free Full Text]
  44. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries: association of osteopontin with atherosclerosis. J Clin Invest. 1994;94:1597-1604.
  45. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-ß1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 1994;93:2106-2113.




This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiao, J.-H.
Right arrow Articles by Lusis, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiao, J.-H.
Right arrow Articles by Lusis, A. J.